

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 4.46112936 |
| 2 | COPII vesicle coating (GO:0048208) | 4.37436713 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.14156041 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 4.14156041 |
| 5 | nuclear pore organization (GO:0006999) | 4.04491903 |
| 6 | cell adhesion mediated by integrin (GO:0033627) | 3.96102916 |
| 7 | cellular response to ethanol (GO:0071361) | 3.62233373 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 3.57146279 |
| 9 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.55190455 |
| 10 | hepatocyte apoptotic process (GO:0097284) | 3.53244470 |
| 11 | desmosome organization (GO:0002934) | 3.50634326 |
| 12 | growth hormone receptor signaling pathway (GO:0060396) | 3.42949250 |
| 13 | pore complex assembly (GO:0046931) | 3.40710541 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.36939868 |
| 15 | L-phenylalanine metabolic process (GO:0006558) | 3.36939868 |
| 16 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.31770166 |
| 17 | tryptophan metabolic process (GO:0006568) | 3.24854704 |
| 18 | tryptophan catabolic process (GO:0006569) | 3.24827795 |
| 19 | indole-containing compound catabolic process (GO:0042436) | 3.24827795 |
| 20 | indolalkylamine catabolic process (GO:0046218) | 3.24827795 |
| 21 | hemidesmosome assembly (GO:0031581) | 3.23968395 |
| 22 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.21436987 |
| 23 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.15094066 |
| 24 | regulation of bile acid biosynthetic process (GO:0070857) | 3.14454958 |
| 25 | import into cell (GO:0098657) | 3.08472661 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 2.95997094 |
| 27 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.92695801 |
| 28 | regulation of Rac protein signal transduction (GO:0035020) | 2.91412289 |
| 29 | protein carboxylation (GO:0018214) | 2.90643469 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.90643469 |
| 31 | cellular response to growth hormone stimulus (GO:0071378) | 2.88398440 |
| 32 | alpha-linolenic acid metabolic process (GO:0036109) | 2.86543333 |
| 33 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.86119855 |
| 34 | complement activation, alternative pathway (GO:0006957) | 2.86035480 |
| 35 | hypotonic response (GO:0006971) | 2.84871459 |
| 36 | iron ion import (GO:0097286) | 2.84400573 |
| 37 | regulation of alkaline phosphatase activity (GO:0010692) | 2.84351290 |
| 38 | intestinal epithelial cell development (GO:0060576) | 2.84007961 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.82038972 |
| 40 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.80723264 |
| 41 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.80723264 |
| 42 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.80723264 |
| 43 | axon ensheathment in central nervous system (GO:0032291) | 2.79951411 |
| 44 | central nervous system myelination (GO:0022010) | 2.79951411 |
| 45 | urea cycle (GO:0000050) | 2.78385521 |
| 46 | urea metabolic process (GO:0019627) | 2.78385521 |
| 47 | response to interleukin-15 (GO:0070672) | 2.76804985 |
| 48 | fibroblast migration (GO:0010761) | 2.76277289 |
| 49 | membrane raft organization (GO:0031579) | 2.74643994 |
| 50 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.73534749 |
| 51 | cellular glucuronidation (GO:0052695) | 2.73365609 |
| 52 | protein localization to endosome (GO:0036010) | 2.70876474 |
| 53 | phospholipid homeostasis (GO:0055091) | 2.69859972 |
| 54 | tyrosine metabolic process (GO:0006570) | 2.68629106 |
| 55 | Golgi to endosome transport (GO:0006895) | 2.66279960 |
| 56 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.63926456 |
| 57 | cysteine metabolic process (GO:0006534) | 2.61371758 |
| 58 | regulation of protein activation cascade (GO:2000257) | 2.61237993 |
| 59 | kynurenine metabolic process (GO:0070189) | 2.59636497 |
| 60 | negative regulation of protein activation cascade (GO:2000258) | 2.59277445 |
| 61 | regulation of metalloenzyme activity (GO:0048552) | 2.58951236 |
| 62 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.57104793 |
| 63 | homocysteine metabolic process (GO:0050667) | 2.56268242 |
| 64 | embryonic process involved in female pregnancy (GO:0060136) | 2.56093582 |
| 65 | negative regulation of fibrinolysis (GO:0051918) | 2.55811321 |
| 66 | bile acid biosynthetic process (GO:0006699) | 2.54282504 |
| 67 | bile acid metabolic process (GO:0008206) | 2.54171767 |
| 68 | genitalia morphogenesis (GO:0035112) | 2.52582622 |
| 69 | vesicle coating (GO:0006901) | 2.52405903 |
| 70 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.51552626 |
| 71 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.51552626 |
| 72 | valine metabolic process (GO:0006573) | 2.51301554 |
| 73 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.50872538 |
| 74 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.50692249 |
| 75 | regulation of complement activation (GO:0030449) | 2.50656448 |
| 76 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.49869019 |
| 77 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.49465317 |
| 78 | cellular biogenic amine catabolic process (GO:0042402) | 2.49308797 |
| 79 | amine catabolic process (GO:0009310) | 2.49308797 |
| 80 | positive regulation of protein autophosphorylation (GO:0031954) | 2.48526239 |
| 81 | plasma lipoprotein particle assembly (GO:0034377) | 2.47276059 |
| 82 | protein-lipid complex assembly (GO:0065005) | 2.47273096 |
| 83 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.46141939 |
| 84 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.45997656 |
| 85 | necroptotic process (GO:0070266) | 2.45852148 |
| 86 | positive regulation of macroautophagy (GO:0016239) | 2.45816108 |
| 87 | midgut development (GO:0007494) | 2.45703707 |
| 88 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.45173395 |
| 89 | cholesterol efflux (GO:0033344) | 2.44757095 |
| 90 | early endosome to late endosome transport (GO:0045022) | 2.43946821 |
| 91 | nitrogen cycle metabolic process (GO:0071941) | 2.42380818 |
| 92 | lipid translocation (GO:0034204) | 2.40484480 |
| 93 | phospholipid translocation (GO:0045332) | 2.40484480 |
| 94 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.39842218 |
| 95 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.38888840 |
| 96 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.38888840 |
| 97 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.38888840 |
| 98 | negative regulation of complement activation (GO:0045916) | 2.38860157 |
| 99 | aromatic amino acid family metabolic process (GO:0009072) | 2.37850180 |
| 100 | regulation of triglyceride catabolic process (GO:0010896) | 2.37670954 |
| 101 | cell wall macromolecule catabolic process (GO:0016998) | 2.37537348 |
| 102 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.36691801 |
| 103 | response to lipoprotein particle (GO:0055094) | 2.35723298 |
| 104 | mesodermal cell differentiation (GO:0048333) | 2.34722834 |
| 105 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.34115849 |
| 106 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.34115849 |
| 107 | regulation of fibrinolysis (GO:0051917) | 2.33961612 |
| 108 | positive regulation of muscle hypertrophy (GO:0014742) | 2.32672913 |
| 109 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.32672913 |
| 110 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.32264767 |
| 111 | macroautophagy (GO:0016236) | 2.31895575 |
| 112 | mitotic sister chromatid cohesion (GO:0007064) | 2.31582017 |
| 113 | urate metabolic process (GO:0046415) | 2.30885264 |
| 114 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.30801979 |
| 115 | cellular response to interleukin-15 (GO:0071350) | 2.30705912 |
| 116 | neutrophil activation involved in immune response (GO:0002283) | 2.30590717 |
| 117 | positive regulation of glycolytic process (GO:0045821) | 2.30415446 |
| 118 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.28133772 |
| 119 | positive regulation of blood coagulation (GO:0030194) | 2.27395725 |
| 120 | positive regulation of hemostasis (GO:1900048) | 2.27395725 |
| 121 | uronic acid metabolic process (GO:0006063) | 2.27316298 |
| 122 | glucuronate metabolic process (GO:0019585) | 2.27316298 |
| 123 | indolalkylamine metabolic process (GO:0006586) | 2.27194477 |
| 124 | cellular response to cholesterol (GO:0071397) | 2.26906301 |
| 125 | Golgi transport vesicle coating (GO:0048200) | 2.26899730 |
| 126 | COPI coating of Golgi vesicle (GO:0048205) | 2.26899730 |
| 127 | positive regulation of coagulation (GO:0050820) | 2.26689888 |
| 128 | glyoxylate metabolic process (GO:0046487) | 2.26509373 |
| 129 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.26060568 |
| 130 | plasma lipoprotein particle clearance (GO:0034381) | 2.25780928 |
| 131 | positive regulation of interferon-alpha production (GO:0032727) | 2.25695833 |
| 132 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.25612084 |
| 133 | regulation of protein polyubiquitination (GO:1902914) | 2.25440586 |
| 134 | ethanol oxidation (GO:0006069) | 2.25115064 |
| 135 | ER overload response (GO:0006983) | 2.24654305 |
| 136 | phospholipid efflux (GO:0033700) | 2.24546137 |
| 137 | bile acid and bile salt transport (GO:0015721) | 2.23989297 |
| 138 | regulation of extracellular matrix disassembly (GO:0010715) | 2.23824769 |
| 139 | I-kappaB phosphorylation (GO:0007252) | 2.23546021 |
| 140 | fatty acid elongation (GO:0030497) | 2.23413314 |
| 141 | pericardium development (GO:0060039) | 2.22930049 |
| 142 | cell wall macromolecule metabolic process (GO:0044036) | 2.21493885 |
| 143 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.20942117 |
| 144 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.20838119 |
| 145 | protein targeting to lysosome (GO:0006622) | 2.20517185 |
| 146 | establishment of protein localization to vacuole (GO:0072666) | 2.20517185 |
| 147 | protein targeting to vacuole (GO:0006623) | 2.20517185 |
| 148 | neutrophil activation (GO:0042119) | 2.19487006 |
| 149 | myelin assembly (GO:0032288) | 2.19362117 |
| 150 | response to cholesterol (GO:0070723) | 2.19230158 |
| 151 | drug transmembrane transport (GO:0006855) | 2.18733650 |
| 152 | linoleic acid metabolic process (GO:0043651) | 2.18430456 |
| 153 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.18198202 |
| 154 | positive regulation of lipid catabolic process (GO:0050996) | 2.16721133 |
| 155 | response to phenylpropanoid (GO:0080184) | 2.16435027 |
| 156 | regulation of keratinocyte differentiation (GO:0045616) | 2.15919313 |
| 157 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.15818459 |
| 158 | reverse cholesterol transport (GO:0043691) | 2.15717215 |
| 159 | regulation of transforming growth factor beta production (GO:0071634) | 2.15276442 |
| 160 | sterol homeostasis (GO:0055092) | 2.14842879 |
| 161 | cholesterol homeostasis (GO:0042632) | 2.14731040 |
| 162 | cellular response to sterol (GO:0036315) | 2.14613404 |
| 163 | purine ribonucleotide transport (GO:0015868) | 2.14555698 |
| 164 | NLS-bearing protein import into nucleus (GO:0006607) | 2.14467829 |
| 165 | establishment of protein localization to Golgi (GO:0072600) | 2.13945592 |
| 166 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.13767125 |
| 167 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.13767125 |
| 168 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.13767125 |
| 169 | modulation by symbiont of host immune response (GO:0052553) | 2.13767125 |
| 170 | positive regulation by symbiont of host defense response (GO:0052509) | 2.13767125 |
| 171 | modulation by symbiont of host defense response (GO:0052031) | 2.13767125 |
| 172 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.13632300 |
| 173 | protein K11-linked deubiquitination (GO:0035871) | 2.13401588 |
| 174 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.13352056 |
| 175 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.13352056 |
| 176 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.12648020 |
| 177 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.12648020 |
| 178 | positive regulation of fibroblast migration (GO:0010763) | 2.12065510 |
| 179 | regulation of interferon-alpha production (GO:0032647) | 2.11322571 |
| 180 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.11077391 |
| 181 | negative regulation of TOR signaling (GO:0032007) | 2.10729762 |
| 182 | wound healing, spreading of epidermal cells (GO:0035313) | 2.10056277 |
| 183 | Golgi organization (GO:0007030) | 2.09468220 |
| 184 | mammary gland epithelial cell proliferation (GO:0033598) | 2.09428763 |
| 185 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.08599343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.38391043 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.02804379 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.89406416 |
| 4 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.66395300 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.53627796 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.48187295 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.39359477 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.25980253 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.19156302 |
| 10 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.18803122 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.07726640 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.96326334 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.95922864 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.95855990 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.88993639 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.88049282 |
| 17 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87974179 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.86928522 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.85667259 |
| 20 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85623079 |
| 21 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.85526884 |
| 22 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.82034575 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.79453513 |
| 24 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.78830682 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.76535335 |
| 26 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.76407922 |
| 27 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.69933485 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.66733600 |
| 29 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.66425938 |
| 30 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.66303639 |
| 31 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.57709822 |
| 32 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.53051554 |
| 33 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.53051554 |
| 34 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.51987300 |
| 35 | TP53_16413492_ChIP-PET_HCT116_Human | 1.51084794 |
| 36 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.50112012 |
| 37 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.49526123 |
| 38 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.47883312 |
| 39 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.44147179 |
| 40 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43510435 |
| 41 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.41163031 |
| 42 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.40786688 |
| 43 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.40058941 |
| 44 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.39889680 |
| 45 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.37989558 |
| 46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.37943398 |
| 47 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.37694257 |
| 48 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.36510916 |
| 49 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.35992601 |
| 50 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.35004083 |
| 51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.33847043 |
| 52 | RXR_22108803_ChIP-Seq_LS180_Human | 1.32893511 |
| 53 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.32553670 |
| 54 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.32514065 |
| 55 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.32349899 |
| 56 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.30152399 |
| 57 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.28855548 |
| 58 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.28518363 |
| 59 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.26462416 |
| 60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26108834 |
| 61 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.26107904 |
| 62 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.24846232 |
| 63 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24374677 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23926550 |
| 65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23414809 |
| 66 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.20918610 |
| 67 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.20668365 |
| 68 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.20083776 |
| 69 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.19871666 |
| 70 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18752762 |
| 71 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.18093090 |
| 72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.17623066 |
| 73 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.17456913 |
| 74 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.17132492 |
| 75 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.16947861 |
| 76 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16921468 |
| 77 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16265924 |
| 78 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.15022153 |
| 79 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14464785 |
| 80 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14460888 |
| 81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13838886 |
| 82 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13657056 |
| 83 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.12871645 |
| 84 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12673265 |
| 85 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.11856526 |
| 86 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.11268435 |
| 87 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.11268047 |
| 88 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.11002997 |
| 89 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10688785 |
| 90 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.10459401 |
| 91 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.09884214 |
| 92 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.09411471 |
| 93 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.09323732 |
| 94 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09229082 |
| 95 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09075302 |
| 96 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.08966988 |
| 97 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.08071910 |
| 98 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.07761340 |
| 99 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.07215933 |
| 100 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.06607238 |
| 101 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.05889593 |
| 102 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.05888524 |
| 103 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05644228 |
| 104 | FUS_26573619_Chip-Seq_HEK293_Human | 1.05305231 |
| 105 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05196634 |
| 106 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04467025 |
| 107 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.04261119 |
| 108 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.03631890 |
| 109 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.02128231 |
| 110 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.02128231 |
| 111 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02052880 |
| 112 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.01536651 |
| 113 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.01359377 |
| 114 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.01089304 |
| 115 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.00894037 |
| 116 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00861440 |
| 117 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00735649 |
| 118 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.00468492 |
| 119 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00060795 |
| 120 | P300_19829295_ChIP-Seq_ESCs_Human | 0.99920908 |
| 121 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.99732414 |
| 122 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.99176335 |
| 123 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98431293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.15987750 |
| 2 | MP0005360_urolithiasis | 3.91606898 |
| 3 | MP0010352_gastrointestinal_tract_polyps | 3.35290865 |
| 4 | MP0005365_abnormal_bile_salt | 3.31118058 |
| 5 | MP0003252_abnormal_bile_duct | 3.30584255 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 3.09355791 |
| 7 | MP0008057_abnormal_DNA_replication | 2.91918085 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 2.85446496 |
| 9 | MP0006054_spinal_hemorrhage | 2.85393767 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.61173932 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.55242168 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.50509269 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.37018877 |
| 14 | MP0000569_abnormal_digit_pigmentation | 2.22957034 |
| 15 | MP0003950_abnormal_plasma_membrane | 2.22904105 |
| 16 | MP0002877_abnormal_melanocyte_morpholog | 2.18078335 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.08732966 |
| 18 | MP0010678_abnormal_skin_adnexa | 1.96668624 |
| 19 | MP0003690_abnormal_glial_cell | 1.96039289 |
| 20 | MP0001835_abnormal_antigen_presentation | 1.94915417 |
| 21 | MP0000383_abnormal_hair_follicle | 1.88373966 |
| 22 | MP0003566_abnormal_cell_adhesion | 1.77167341 |
| 23 | MP0003656_abnormal_erythrocyte_physiolo | 1.70853833 |
| 24 | MP0000920_abnormal_myelination | 1.69740938 |
| 25 | MP0005164_abnormal_response_to | 1.62604171 |
| 26 | MP0010329_abnormal_lipoprotein_level | 1.59372751 |
| 27 | MP0001666_abnormal_nutrient_absorption | 1.56892905 |
| 28 | MP0003868_abnormal_feces_composition | 1.54489041 |
| 29 | MP0001661_extended_life_span | 1.52709021 |
| 30 | MP0003828_pulmonary_edema | 1.47749637 |
| 31 | MP0004883_abnormal_blood_vessel | 1.47247095 |
| 32 | MP0002419_abnormal_innate_immunity | 1.45040595 |
| 33 | MP0005387_immune_system_phenotype | 1.44158095 |
| 34 | MP0001790_abnormal_immune_system | 1.44158095 |
| 35 | MP0005332_abnormal_amino_acid | 1.42692371 |
| 36 | MP0000566_synostosis | 1.42111632 |
| 37 | MP0005671_abnormal_response_to | 1.35215369 |
| 38 | MP0003045_fibrosis | 1.33976209 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.32595673 |
| 40 | MP0006082_CNS_inflammation | 1.30043002 |
| 41 | MP0002060_abnormal_skin_morphology | 1.29332829 |
| 42 | MP0005451_abnormal_body_composition | 1.28810179 |
| 43 | MP0000015_abnormal_ear_pigmentation | 1.26885952 |
| 44 | MP0005248_abnormal_Harderian_gland | 1.26727827 |
| 45 | MP0009697_abnormal_copulation | 1.26521869 |
| 46 | MP0002928_abnormal_bile_duct | 1.26426991 |
| 47 | MP0000013_abnormal_adipose_tissue | 1.25249022 |
| 48 | MP0000465_gastrointestinal_hemorrhage | 1.24996627 |
| 49 | MP0004272_abnormal_basement_membrane | 1.19329977 |
| 50 | MP0004264_abnormal_extraembryonic_tissu | 1.18566010 |
| 51 | MP0008438_abnormal_cutaneous_collagen | 1.15571990 |
| 52 | MP0001851_eye_inflammation | 1.15353029 |
| 53 | MP0009384_cardiac_valve_regurgitation | 1.13676345 |
| 54 | MP0002168_other_aberrant_phenotype | 1.12872488 |
| 55 | MP0010307_abnormal_tumor_latency | 1.12408011 |
| 56 | MP0001800_abnormal_humoral_immune | 1.11808870 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.11641902 |
| 58 | MP0000609_abnormal_liver_physiology | 1.11611626 |
| 59 | MP0004484_altered_response_of | 1.11559372 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.11412099 |
| 61 | MP0005275_abnormal_skin_tensile | 1.11066690 |
| 62 | MP0000003_abnormal_adipose_tissue | 1.11062649 |
| 63 | MP0002452_abnormal_antigen_presenting | 1.10666394 |
| 64 | MP0003763_abnormal_thymus_physiology | 1.10386598 |
| 65 | MP0003195_calcinosis | 1.08342193 |
| 66 | * MP0001216_abnormal_epidermal_layer | 1.07902817 |
| 67 | MP0002118_abnormal_lipid_homeostasis | 1.07299549 |
| 68 | MP0003705_abnormal_hypodermis_morpholog | 1.06617647 |
| 69 | MP0009764_decreased_sensitivity_to | 1.06181454 |
| 70 | MP0009643_abnormal_urine_homeostasis | 1.04714240 |
| 71 | MP0002933_joint_inflammation | 1.04282973 |
| 72 | MP0005670_abnormal_white_adipose | 1.03848855 |
| 73 | MP0005058_abnormal_lysosome_morphology | 1.02890239 |
| 74 | MP0003172_abnormal_lysosome_physiology | 1.02878464 |
| 75 | MP0005408_hypopigmentation | 1.02258661 |
| 76 | MP0002396_abnormal_hematopoietic_system | 1.01500900 |
| 77 | MP0010234_abnormal_vibrissa_follicle | 1.00908408 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 0.99833063 |
| 79 | MP0001958_emphysema | 0.99175060 |
| 80 | MP0009763_increased_sensitivity_to | 0.96357009 |
| 81 | MP0002998_abnormal_bone_remodeling | 0.96109245 |
| 82 | MP0002723_abnormal_immune_serum | 0.91619468 |
| 83 | MP0002136_abnormal_kidney_physiology | 0.90245848 |
| 84 | MP0005000_abnormal_immune_tolerance | 0.90006082 |
| 85 | MP0004381_abnormal_hair_follicle | 0.89961175 |
| 86 | MP0009115_abnormal_fat_cell | 0.89167902 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.88333734 |
| 88 | MP0000627_abnormal_mammary_gland | 0.88043848 |
| 89 | MP0003724_increased_susceptibility_to | 0.88026986 |
| 90 | MP0003943_abnormal_hepatobiliary_system | 0.87879191 |
| 91 | MP0009840_abnormal_foam_cell | 0.87620551 |
| 92 | MP0005023_abnormal_wound_healing | 0.87245505 |
| 93 | MP0010368_abnormal_lymphatic_system | 0.86489570 |
| 94 | MP0004947_skin_inflammation | 0.85104098 |
| 95 | MP0005171_absent_coat_pigmentation | 0.84785288 |
| 96 | MP0003436_decreased_susceptibility_to | 0.84358327 |
| 97 | MP0002420_abnormal_adaptive_immunity | 0.84142684 |
| 98 | MP0001819_abnormal_immune_cell | 0.84113587 |
| 99 | MP0001177_atelectasis | 0.84036007 |
| 100 | MP0005025_abnormal_response_to | 0.83729600 |
| 101 | MP0001533_abnormal_skeleton_physiology | 0.82718861 |
| 102 | MP0010155_abnormal_intestine_physiology | 0.82717753 |
| 103 | MP0005464_abnormal_platelet_physiology | 0.81713845 |
| 104 | MP0000371_diluted_coat_color | 0.81504273 |
| 105 | MP0003448_altered_tumor_morphology | 0.81423545 |
| 106 | MP0000462_abnormal_digestive_system | 0.80527715 |
| 107 | MP0002086_abnormal_extraembryonic_tissu | 0.79842897 |
| 108 | MP0001915_intracranial_hemorrhage | 0.79178514 |
| 109 | MP0002009_preneoplasia | 0.78739058 |
| 110 | MP0002006_tumorigenesis | 0.78454125 |
| 111 | MP0008260_abnormal_autophagy | 0.78089173 |
| 112 | MP0004134_abnormal_chest_morphology | 0.77660687 |
| 113 | * MP0001845_abnormal_inflammatory_respons | 0.77326234 |
| 114 | MP0002132_abnormal_respiratory_system | 0.76767521 |
| 115 | MP0002254_reproductive_system_inflammat | 0.75244087 |
| 116 | MP0000604_amyloidosis | 0.75133493 |
| 117 | MP0001191_abnormal_skin_condition | 0.72683775 |
| 118 | MP0004808_abnormal_hematopoietic_stem | 0.72044210 |
| 119 | MP0003091_abnormal_cell_migration | 0.72022614 |
| 120 | MP0002896_abnormal_bone_mineralization | 0.71850821 |
| 121 | MP0003632_abnormal_nervous_system | 0.71219022 |
| 122 | MP0005220_abnormal_exocrine_pancreas | 0.70787480 |
| 123 | MP0005503_abnormal_tendon_morphology | 0.70684969 |
| 124 | MP0005076_abnormal_cell_differentiation | 0.70653058 |
| 125 | MP0003303_peritoneal_inflammation | 0.70601773 |
| 126 | MP0000377_abnormal_hair_follicle | 0.69743052 |
| 127 | MP0008469_abnormal_protein_level | 0.69483500 |
| 128 | MP0000427_abnormal_hair_cycle | 0.69098529 |
| 129 | MP0003937_abnormal_limbs/digits/tail_de | 0.68561158 |
| 130 | MP0005334_abnormal_fat_pad | 0.68086024 |
| 131 | MP0009785_altered_susceptibility_to | 0.67119158 |
| 132 | MP0000647_abnormal_sebaceous_gland | 0.67114054 |
| 133 | MP0001879_abnormal_lymphatic_vessel | 0.66992647 |
| 134 | MP0000598_abnormal_liver_morphology | 0.66954070 |
| 135 | MP0005621_abnormal_cell_physiology | 0.66620236 |
| 136 | MP0001853_heart_inflammation | 0.66403579 |
| 137 | MP0002332_abnormal_exercise_endurance | 0.66006278 |
| 138 | MP0005375_adipose_tissue_phenotype | 0.64045710 |
| 139 | MP0005376_homeostasis/metabolism_phenot | 0.62832541 |
| 140 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62557337 |
| 141 | * MP0002405_respiratory_system_inflammati | 0.58816669 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Subacute progressive viral hepatitis (HP:0006572) | 3.63471086 |
| 2 | Papillary thyroid carcinoma (HP:0002895) | 3.56486136 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 3.18154662 |
| 4 | Curly hair (HP:0002212) | 3.11851287 |
| 5 | Autoimmune hemolytic anemia (HP:0001890) | 2.99138949 |
| 6 | Hematochezia (HP:0002573) | 2.88258158 |
| 7 | Abnormality of methionine metabolism (HP:0010901) | 2.87748722 |
| 8 | Stomach cancer (HP:0012126) | 2.84624891 |
| 9 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.76491924 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 2.66137265 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.65916635 |
| 12 | Ankyloglossia (HP:0010296) | 2.65268696 |
| 13 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.65099964 |
| 14 | Complement deficiency (HP:0004431) | 2.63690778 |
| 15 | Abnormality of incisor morphology (HP:0011063) | 2.63088603 |
| 16 | Arterial tortuosity (HP:0005116) | 2.62525867 |
| 17 | Deep venous thrombosis (HP:0002625) | 2.61484888 |
| 18 | Enlarged kidneys (HP:0000105) | 2.58142988 |
| 19 | Hypolipoproteinemia (HP:0010981) | 2.56086921 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.54242632 |
| 21 | Cutaneous melanoma (HP:0012056) | 2.50551914 |
| 22 | Prolonged partial thromboplastin time (HP:0003645) | 2.49965568 |
| 23 | Thyroid carcinoma (HP:0002890) | 2.49640278 |
| 24 | Myocardial infarction (HP:0001658) | 2.48597715 |
| 25 | Sensory axonal neuropathy (HP:0003390) | 2.48295483 |
| 26 | Abnormality of oral frenula (HP:0000190) | 2.47752492 |
| 27 | Epidermoid cyst (HP:0200040) | 2.46895012 |
| 28 | Xanthomatosis (HP:0000991) | 2.42426370 |
| 29 | Vascular calcification (HP:0004934) | 2.41704348 |
| 30 | Generalized hypopigmentation of hair (HP:0011358) | 2.37608521 |
| 31 | Osteolytic defects of the hand bones (HP:0009699) | 2.36610103 |
| 32 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.36610103 |
| 33 | Cardiovascular calcification (HP:0011915) | 2.35500205 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 2.34502811 |
| 35 | Hypochromic microcytic anemia (HP:0004840) | 2.33668368 |
| 36 | Abnormal foot bone ossification (HP:0010675) | 2.32646015 |
| 37 | Abnormality of the nasal septum (HP:0000419) | 2.30433870 |
| 38 | Fat malabsorption (HP:0002630) | 2.29048883 |
| 39 | Eczematoid dermatitis (HP:0000976) | 2.26979538 |
| 40 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.26883652 |
| 41 | * Chronic diarrhea (HP:0002028) | 2.26211467 |
| 42 | Submucous cleft hard palate (HP:0000176) | 2.25439807 |
| 43 | Tetraparesis (HP:0002273) | 2.23803839 |
| 44 | Hypoglycemic seizures (HP:0002173) | 2.23050218 |
| 45 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.22232234 |
| 46 | Fair hair (HP:0002286) | 2.21544419 |
| 47 | Joint hemorrhage (HP:0005261) | 2.21523658 |
| 48 | Coarse hair (HP:0002208) | 2.19373008 |
| 49 | Hypoplastic ischia (HP:0003175) | 2.19170120 |
| 50 | Conjugated hyperbilirubinemia (HP:0002908) | 2.18758080 |
| 51 | Vascular tortuosity (HP:0004948) | 2.17290786 |
| 52 | Renal cortical cysts (HP:0000803) | 2.16868336 |
| 53 | Bell-shaped thorax (HP:0001591) | 2.16527834 |
| 54 | Symptomatic seizures (HP:0011145) | 2.14510740 |
| 55 | Hypoplastic labia majora (HP:0000059) | 2.12365456 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 2.11671535 |
| 57 | Hyperglycemia (HP:0003074) | 2.11390235 |
| 58 | Heterotopia (HP:0002282) | 2.11247181 |
| 59 | Glomerulonephritis (HP:0000099) | 2.11219817 |
| 60 | Asymmetry of the thorax (HP:0001555) | 2.10654427 |
| 61 | Abnormal auditory evoked potentials (HP:0006958) | 2.09084605 |
| 62 | Glucose intolerance (HP:0000833) | 2.08730083 |
| 63 | Neoplasm of the adrenal cortex (HP:0100641) | 2.07435339 |
| 64 | Alopecia of scalp (HP:0002293) | 2.07406270 |
| 65 | Abnormality of the fingertips (HP:0001211) | 2.05864083 |
| 66 | Recurrent bacterial skin infections (HP:0005406) | 2.05492205 |
| 67 | Gingival bleeding (HP:0000225) | 2.04551494 |
| 68 | Abnormality of the ischium (HP:0003174) | 2.04294654 |
| 69 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.03786634 |
| 70 | Abnormality of homocysteine metabolism (HP:0010919) | 2.03529221 |
| 71 | Homocystinuria (HP:0002156) | 2.03529221 |
| 72 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.01259706 |
| 73 | Vitreoretinal degeneration (HP:0000655) | 2.01117092 |
| 74 | Freckling (HP:0001480) | 2.00117244 |
| 75 | Aortic dissection (HP:0002647) | 1.98856048 |
| 76 | Menstrual irregularities (HP:0000858) | 1.98526840 |
| 77 | Hypoalphalipoproteinemia (HP:0003233) | 1.98142530 |
| 78 | Bladder neoplasm (HP:0009725) | 1.98114951 |
| 79 | Bladder carcinoma (HP:0002862) | 1.98114951 |
| 80 | Milia (HP:0001056) | 1.97284795 |
| 81 | Abnormality of complement system (HP:0005339) | 1.97192511 |
| 82 | Micronodular cirrhosis (HP:0001413) | 1.96729719 |
| 83 | Hamartoma of the eye (HP:0010568) | 1.96315522 |
| 84 | Ectropion (HP:0000656) | 1.95234349 |
| 85 | Spondylolisthesis (HP:0003302) | 1.94641483 |
| 86 | Plantar hyperkeratosis (HP:0007556) | 1.94580501 |
| 87 | Steatorrhea (HP:0002570) | 1.93449297 |
| 88 | Abnormality of the labia majora (HP:0012881) | 1.92447881 |
| 89 | Abnormality of macrophages (HP:0004311) | 1.92132895 |
| 90 | Gingivitis (HP:0000230) | 1.90631261 |
| 91 | Recurrent abscess formation (HP:0002722) | 1.90624253 |
| 92 | Albinism (HP:0001022) | 1.89240748 |
| 93 | Abnormal biliary tract morphology (HP:0012440) | 1.88585025 |
| 94 | Right ventricular cardiomyopathy (HP:0011663) | 1.88345835 |
| 95 | Metabolic alkalosis (HP:0200114) | 1.87811642 |
| 96 | Absent frontal sinuses (HP:0002688) | 1.86463855 |
| 97 | Blepharitis (HP:0000498) | 1.86278589 |
| 98 | Volvulus (HP:0002580) | 1.86072435 |
| 99 | Mitral stenosis (HP:0001718) | 1.84630167 |
| 100 | Periodontitis (HP:0000704) | 1.84127976 |
| 101 | Epiphyseal dysplasia (HP:0002656) | 1.82733816 |
| 102 | Abnormality of the renal cortex (HP:0011035) | 1.82123506 |
| 103 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.81702928 |
| 104 | Thyroiditis (HP:0100646) | 1.80282918 |
| 105 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.79539611 |
| 106 | Scanning speech (HP:0002168) | 1.79434053 |
| 107 | T lymphocytopenia (HP:0005403) | 1.79250991 |
| 108 | Cubitus valgus (HP:0002967) | 1.78599910 |
| 109 | Increased CSF protein (HP:0002922) | 1.76609558 |
| 110 | Chronic hepatic failure (HP:0100626) | 1.76478770 |
| 111 | Small epiphyses (HP:0010585) | 1.76029250 |
| 112 | Atrophic scars (HP:0001075) | 1.75682271 |
| 113 | Limited elbow extension (HP:0001377) | 1.74367058 |
| 114 | Anteriorly placed anus (HP:0001545) | 1.73735130 |
| 115 | Abnormal glucose tolerance (HP:0001952) | 1.73476714 |
| 116 | Cystic hygroma (HP:0000476) | 1.73277829 |
| 117 | Palmar hyperkeratosis (HP:0010765) | 1.73196450 |
| 118 | Proximal tubulopathy (HP:0000114) | 1.72726049 |
| 119 | Hypercholesterolemia (HP:0003124) | 1.72472703 |
| 120 | Vacuolated lymphocytes (HP:0001922) | 1.72411060 |
| 121 | Onycholysis (HP:0001806) | 1.70364454 |
| 122 | White forelock (HP:0002211) | 1.70254974 |
| 123 | Increased mean platelet volume (HP:0011877) | 1.69664890 |
| 124 | Arterial thrombosis (HP:0004420) | 1.68487382 |
| 125 | Esophageal varix (HP:0002040) | 1.67380111 |
| 126 | Abnormality of T cell number (HP:0011839) | 1.66292937 |
| 127 | Aqueductal stenosis (HP:0002410) | 1.66274934 |
| 128 | Gastrointestinal infarctions (HP:0005244) | 1.66104137 |
| 129 | Orchitis (HP:0100796) | 1.65980130 |
| 130 | Recurrent skin infections (HP:0001581) | 1.65831915 |
| 131 | Thick nail (HP:0001805) | 1.65429856 |
| 132 | Spinal cord lesions (HP:0100561) | 1.65335845 |
| 133 | Syringomyelia (HP:0003396) | 1.65335845 |
| 134 | Portal hypertension (HP:0001409) | 1.65192508 |
| 135 | Hydroxyprolinuria (HP:0003080) | 1.64548199 |
| 136 | Abnormality of proline metabolism (HP:0010907) | 1.64548199 |
| 137 | Somatic mutation (HP:0001428) | 1.64388872 |
| 138 | Hypobetalipoproteinemia (HP:0003563) | 1.63502680 |
| 139 | Cone-rod dystrophy (HP:0000548) | 1.62896772 |
| 140 | Eosinophilia (HP:0001880) | 1.62571013 |
| 141 | Pulmonic stenosis (HP:0001642) | 1.62300335 |
| 142 | Deep philtrum (HP:0002002) | 1.61968596 |
| 143 | Pustule (HP:0200039) | 1.61685895 |
| 144 | Macroorchidism (HP:0000053) | 1.61103276 |
| 145 | Abnormal platelet volume (HP:0011876) | 1.60889724 |
| 146 | Prostate neoplasm (HP:0100787) | 1.59618187 |
| 147 | Hepatocellular carcinoma (HP:0001402) | 1.58714828 |
| 148 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.57941840 |
| 149 | Optic neuritis (HP:0100653) | 1.57850663 |
| 150 | Retrobulbar optic neuritis (HP:0100654) | 1.57850663 |
| 151 | Patchy hypopigmentation of hair (HP:0011365) | 1.57603804 |
| 152 | Acute myeloid leukemia (HP:0004808) | 1.57489850 |
| 153 | Abnormality of the lumbar spine (HP:0100712) | 1.57347720 |
| 154 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.57199052 |
| 155 | Recurrent fungal infections (HP:0002841) | 1.57153494 |
| 156 | Pigmentary retinal degeneration (HP:0001146) | 1.56730693 |
| 157 | Confusion (HP:0001289) | 1.56583989 |
| 158 | Abnormality of chloride homeostasis (HP:0011422) | 1.56424378 |
| 159 | Disproportionate tall stature (HP:0001519) | 1.56279901 |
| 160 | Clitoromegaly (HP:0000057) | 1.56045182 |
| 161 | Chorioretinal atrophy (HP:0000533) | 1.55706252 |
| 162 | Abnormality of the hepatic vasculature (HP:0006707) | 1.54571875 |
| 163 | Abnormal hand bone ossification (HP:0010660) | 1.54413062 |
| 164 | Progressive visual loss (HP:0000529) | 1.53169564 |
| 165 | Bifid scrotum (HP:0000048) | 1.52173200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.34521967 |
| 2 | TXK | 2.74871451 |
| 3 | EPHB1 | 2.69871906 |
| 4 | INSRR | 2.68051637 |
| 5 | EIF2AK3 | 2.60874985 |
| 6 | LATS1 | 2.59345617 |
| 7 | FGFR2 | 2.45151611 |
| 8 | STK39 | 2.39762565 |
| 9 | ZAK | 2.36677666 |
| 10 | MAP3K2 | 2.29262064 |
| 11 | ERBB3 | 2.26309913 |
| 12 | SIK1 | 2.25597613 |
| 13 | NUAK1 | 2.20737821 |
| 14 | IRAK3 | 2.18582530 |
| 15 | NEK9 | 2.11299291 |
| 16 | BMPR2 | 1.99364943 |
| 17 | EIF2AK1 | 1.86189772 |
| 18 | ACVR1B | 1.83351680 |
| 19 | OXSR1 | 1.79375304 |
| 20 | EPHA3 | 1.78364288 |
| 21 | KSR1 | 1.74129817 |
| 22 | MAP3K14 | 1.73756787 |
| 23 | JAK1 | 1.71000903 |
| 24 | STK3 | 1.69247630 |
| 25 | MKNK2 | 1.68028614 |
| 26 | IRAK4 | 1.64305174 |
| 27 | NEK6 | 1.63224083 |
| 28 | STK10 | 1.56543471 |
| 29 | FGFR4 | 1.55917905 |
| 30 | MST4 | 1.55395196 |
| 31 | BRD4 | 1.53267253 |
| 32 | TAOK3 | 1.50581095 |
| 33 | BRSK2 | 1.49936641 |
| 34 | TRIM28 | 1.47262213 |
| 35 | PBK | 1.46408752 |
| 36 | MAP3K12 | 1.44903325 |
| 37 | KSR2 | 1.43369844 |
| 38 | WNK1 | 1.43299571 |
| 39 | CAMK1D | 1.43229409 |
| 40 | CSNK1A1L | 1.42528321 |
| 41 | FGFR3 | 1.39354286 |
| 42 | PDK2 | 1.38532866 |
| 43 | MAP4K1 | 1.38381895 |
| 44 | SCYL2 | 1.32482257 |
| 45 | MAP3K9 | 1.30368705 |
| 46 | MET | 1.30129995 |
| 47 | FER | 1.28590656 |
| 48 | TYK2 | 1.26310415 |
| 49 | PLK2 | 1.23351252 |
| 50 | PIK3CA | 1.23066528 |
| 51 | SGK2 | 1.20312535 |
| 52 | CDK6 | 1.17259028 |
| 53 | CAMK1G | 1.16972430 |
| 54 | TRPM7 | 1.14548728 |
| 55 | STK38 | 1.13521439 |
| 56 | ITK | 1.12939867 |
| 57 | MAP3K13 | 1.10618352 |
| 58 | CDK12 | 1.09372272 |
| 59 | RAF1 | 1.09092692 |
| 60 | CAMKK2 | 1.09000256 |
| 61 | SGK223 | 1.08958807 |
| 62 | SGK494 | 1.08958807 |
| 63 | MAP3K3 | 1.04026662 |
| 64 | AKT3 | 1.02151351 |
| 65 | CSK | 1.01291742 |
| 66 | MKNK1 | 1.00002721 |
| 67 | MAPK7 | 0.97565114 |
| 68 | PDGFRB | 0.97228853 |
| 69 | CLK1 | 0.97202389 |
| 70 | STK4 | 0.94118376 |
| 71 | PAK3 | 0.93669262 |
| 72 | PDGFRA | 0.93329021 |
| 73 | TGFBR2 | 0.90339644 |
| 74 | CSF1R | 0.89950710 |
| 75 | PRKCQ | 0.88412251 |
| 76 | TEC | 0.84707738 |
| 77 | IRAK1 | 0.80662105 |
| 78 | PLK4 | 0.79783921 |
| 79 | PKN1 | 0.79366433 |
| 80 | CHUK | 0.78917981 |
| 81 | * SGK3 | 0.77800064 |
| 82 | MARK3 | 0.75942888 |
| 83 | CSNK1G1 | 0.75938884 |
| 84 | FGR | 0.75447769 |
| 85 | BLK | 0.74393308 |
| 86 | JAK3 | 0.74229070 |
| 87 | ERBB4 | 0.74211585 |
| 88 | MST1R | 0.71836449 |
| 89 | IRAK2 | 0.71619152 |
| 90 | MELK | 0.70321631 |
| 91 | WNK4 | 0.69944746 |
| 92 | PTK6 | 0.69298370 |
| 93 | PTK2 | 0.67253786 |
| 94 | IKBKE | 0.66296634 |
| 95 | CDK9 | 0.66285448 |
| 96 | PRKAA2 | 0.65680152 |
| 97 | TNIK | 0.65626005 |
| 98 | IKBKB | 0.64817277 |
| 99 | GSK3A | 0.64724613 |
| 100 | BMPR1B | 0.64707997 |
| 101 | NLK | 0.62516299 |
| 102 | MAP2K1 | 0.62302301 |
| 103 | SIK3 | 0.59902318 |
| 104 | ABL1 | 0.58609053 |
| 105 | RET | 0.58090462 |
| 106 | IGF1R | 0.56865590 |
| 107 | MOS | 0.56332732 |
| 108 | STK24 | 0.55570630 |
| 109 | LCK | 0.55338828 |
| 110 | FGFR1 | 0.54535703 |
| 111 | ERBB2 | 0.53303931 |
| 112 | PDK1 | 0.50538545 |
| 113 | HIPK2 | 0.50534827 |
| 114 | ZAP70 | 0.50115388 |
| 115 | EPHA2 | 0.49307157 |
| 116 | YES1 | 0.48690763 |
| 117 | BTK | 0.48589101 |
| 118 | HCK | 0.48567189 |
| 119 | LYN | 0.47868489 |
| 120 | RPS6KB1 | 0.47389121 |
| 121 | GRK1 | 0.47323881 |
| 122 | EIF2AK2 | 0.47014502 |
| 123 | BCR | 0.46970671 |
| 124 | KIT | 0.46564789 |
| 125 | FLT3 | 0.45307199 |
| 126 | JAK2 | 0.44459291 |
| 127 | INSR | 0.44242517 |
| 128 | MAP3K1 | 0.43644593 |
| 129 | EGFR | 0.43422626 |
| 130 | CSNK1G3 | 0.43063981 |
| 131 | MAP3K7 | 0.42947184 |
| 132 | STK38L | 0.42580712 |
| 133 | RIPK1 | 0.42280121 |
| 134 | MAP2K3 | 0.42244613 |
| 135 | GRK7 | 0.41627622 |
| 136 | NEK1 | 0.41600370 |
| 137 | MAPK11 | 0.36567381 |
| 138 | RPS6KA5 | 0.36432300 |
| 139 | PDPK1 | 0.34374300 |
| 140 | PTK2B | 0.32105384 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.89262950 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.50524843 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.48343719 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.26212948 |
| 5 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.26198452 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.05277240 |
| 7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.99428298 |
| 8 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.92135316 |
| 9 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89226416 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.80658834 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.68666308 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.68342043 |
| 13 | Lysine degradation_Homo sapiens_hsa00310 | 1.63128253 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.63071468 |
| 15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.62037904 |
| 16 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61439215 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.57347328 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.55910223 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.52071202 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.50376852 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.46535787 |
| 22 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.45902183 |
| 23 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.44779800 |
| 24 | ABC transporters_Homo sapiens_hsa02010 | 1.44192028 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.43983463 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.43469220 |
| 27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.43459725 |
| 28 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.42187991 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.39557386 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.38405797 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.38056079 |
| 32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.36846665 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.34584396 |
| 34 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.32793848 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.30243210 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 1.30086843 |
| 37 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.30039833 |
| 38 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.27118105 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.26782310 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.26026322 |
| 41 | Thyroid cancer_Homo sapiens_hsa05216 | 1.25538353 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.23282074 |
| 43 | Glioma_Homo sapiens_hsa05214 | 1.18677934 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.17386159 |
| 45 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.16811853 |
| 46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.16615912 |
| 47 | Endometrial cancer_Homo sapiens_hsa05213 | 1.14413260 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.13142860 |
| 49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.09189750 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.08740790 |
| 51 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.08239510 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.07621761 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.07353507 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.02811824 |
| 55 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.02654092 |
| 56 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.02452640 |
| 57 | Focal adhesion_Homo sapiens_hsa04510 | 1.02123829 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.01403319 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 0.97978741 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.97701913 |
| 61 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92981266 |
| 62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92671324 |
| 63 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.92392901 |
| 64 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.92281486 |
| 65 | Bile secretion_Homo sapiens_hsa04976 | 0.91925417 |
| 66 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.91807358 |
| 67 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.89152856 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87287137 |
| 69 | Amoebiasis_Homo sapiens_hsa05146 | 0.85228100 |
| 70 | * TNF signaling pathway_Homo sapiens_hsa04668 | 0.83316296 |
| 71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.83302079 |
| 72 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.80516678 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 0.80282849 |
| 74 | Malaria_Homo sapiens_hsa05144 | 0.79877500 |
| 75 | Tuberculosis_Homo sapiens_hsa05152 | 0.79690680 |
| 76 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.79599361 |
| 77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.78709865 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.78283504 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77935563 |
| 80 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77815588 |
| 81 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.77004112 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76817114 |
| 83 | Mineral absorption_Homo sapiens_hsa04978 | 0.76363108 |
| 84 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.76169431 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.76167147 |
| 86 | Lysosome_Homo sapiens_hsa04142 | 0.75328817 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75103815 |
| 88 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.72700935 |
| 89 | Leishmaniasis_Homo sapiens_hsa05140 | 0.72118618 |
| 90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71993061 |
| 91 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71529435 |
| 92 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.71057703 |
| 93 | Prostate cancer_Homo sapiens_hsa05215 | 0.70678155 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69029876 |
| 95 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.68811224 |
| 96 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.68752013 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67983826 |
| 98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64474219 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64116023 |
| 100 | Measles_Homo sapiens_hsa05162 | 0.64031519 |
| 101 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.63347950 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62649100 |
| 103 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62454446 |
| 104 | Adherens junction_Homo sapiens_hsa04520 | 0.61822537 |
| 105 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61496437 |
| 106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61202073 |
| 107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60345796 |
| 108 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60274601 |
| 109 | Melanoma_Homo sapiens_hsa05218 | 0.60241129 |
| 110 | Pertussis_Homo sapiens_hsa05133 | 0.60196235 |
| 111 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60119833 |
| 112 | Apoptosis_Homo sapiens_hsa04210 | 0.60096721 |
| 113 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.59407251 |
| 114 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59302640 |
| 115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58847397 |
| 116 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.58501575 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57591220 |
| 118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57286375 |
| 119 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56419830 |
| 120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56215156 |
| 121 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55818163 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55662526 |
| 123 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54847028 |
| 124 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54004876 |
| 125 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53030915 |
| 126 | Hepatitis C_Homo sapiens_hsa05160 | 0.52678890 |
| 127 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51233910 |
| 128 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48674791 |
| 129 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48510699 |
| 130 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48190474 |
| 131 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48162403 |
| 132 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48036596 |
| 133 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47649245 |
| 134 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47443340 |
| 135 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47305799 |
| 136 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47004338 |
| 137 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46657583 |
| 138 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.46585480 |
| 139 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.46584643 |
| 140 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.46471696 |
| 141 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46452038 |
| 142 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.45458602 |
| 143 | Insulin resistance_Homo sapiens_hsa04931 | 0.45449857 |
| 144 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44802861 |
| 145 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44431879 |
| 146 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42984090 |
| 147 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.41707951 |
| 148 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.41273142 |
| 149 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41158164 |
| 150 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36168899 |
| 151 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.35878505 |
| 152 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35382820 |
| 153 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.34364193 |
| 154 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.33972214 |

